Studies in cancer have shown that integrin signaling can mediate the activation of the EMT program induced by other factors present in the tumor microenvironment, such as the epidermal growth factor (EGF), the fibroblast growth factor (FGF), and the pituitary tumor-transforming gene (PTTG) [23,24,25]. The gene discussed is EGF; the disease is cancer.